China Shineway Pharmaceutical Group Limited
OTC: CSWYF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Zhenjiang Li
- Employees
- 3,220
- Headquarters
- Shijiazhuang, China
- IPO year
- 2020
- Market cap
- $758.4M
- Website
- https://www.shineway.com
Loading CSWYF…
Loading profile data…Frequently asked questions about CSWYF
What does China Shineway Pharmaceutical Group Limited (CSWYF) do?
China Shineway Pharmaceutical Group Limited functions as an investment holding company, primarily engaged in the development, manufacturing, and commercialization of traditional Chinese medicines. Its operations span across the People's Republic of China and Hong Kong. The company's diverse product portfolio includes contemporary Chinese medicin...
Where does CSWYF trade?
China Shineway Pharmaceutical Group Limited (CSWYF) trades on the Other OTC.
What sector is CSWYF in?
China Shineway Pharmaceutical Group Limited (CSWYF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of China Shineway Pharmaceutical Group Limited?
Zhenjiang Li is the chief executive officer of China Shineway Pharmaceutical Group Limited (CSWYF).
Where is China Shineway Pharmaceutical Group Limited headquartered?
China Shineway Pharmaceutical Group Limited is headquartered in China.
Does CSWYF pay a dividend?
Yes — China Shineway Pharmaceutical Group Limited (CSWYF) paid a trailing twelve-month dividend of USD 0.08 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did CSWYF go public?
China Shineway Pharmaceutical Group Limited (CSWYF) completed its initial public offering in 2020.